Delivery Order SPE2DB24D2205-SPE2DB26FDSTZ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials, with a ceiling value of $42,011.63. This firm fixed-price delivery order, which is set to be completed by August 5, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement within the Defense Logistics Agency's medical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml injections, with a contract ceiling value of $6,266.60. This delivery order represents a competitive, non-set-aside award utilizing firm fixed price terms and is scheduled for ultimate completion by October 24, 2025. The contract will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials with a ceiling value of $1,253.32. This is a firm fixed-price delivery order with an ultimate completion date of October 17, 2025, and was awarded on a competitive, non-set-aside basis. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) in 3 ml vials, with a contract ceiling value of $5,243.63. This firm fixed-price delivery order, which has an ultimate completion date of July 25, 2025, will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award utilized no set-aside designation and was competitively awarded through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials, with a ceiling value of $8,146.58 and an ultimate completion date of September 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's pharmaceutical supply services under the Defense Logistics Agency's Medical Supply Chain...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials, with a ceiling value of $1,303.59. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of October 27, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials, with a ceiling value of $1,758.99. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) pharmaceutical product at a ceiling value of $56,387.11. This firm fixed-price delivery order, with an ultimate completion date of October 22, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL quantities, with a ceiling value of $62,122.44. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the vendor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials, with a ceiling value of $24,664.43. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion by October 28, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB26FDSTZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL quantities, with a contract ceiling value of $11,428.44. This firm fixed-price delivery order, which utilizes non-competitive set-aside procurement, is scheduled for completion by October 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a discrete delivery against AmerisourceBergen's broader pharmaceutical supply framework supporting Department of Defense and military healthcare operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), a $999.9 billion prime vendor agreement running through December 2026 that enables comprehensive global pharmaceutical support across multiple therapeutic domains. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains an extensive portfolio of competitively awarded contracts supplying medications, vaccines, medical devices, and specialized healthcare commodities to military and veteran healthcare systems. This Ozempic order exemplifies the company's role in providing brand-name pharmaceutical products to support the Defense Health Agency and other federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 10/27/25 |